[ Price : $8.95]
Genta says the AGENDA Phase 3 trial of Genasense failed to meet a co-primary endpoint and secondary endpoints.[ Price : $8.95]
Novartis says it has almost tripled H1N1 vaccine yield after moving to a newer seed virus and production has been accelerating as ...[ Price : $8.95]
AstraZeneca withdraws its NDA Zactima (vandetanib) 100mg in combination with chemotherapy that sought approval for use in patients...[ Price : $8.95]
Qualitest Pharmaceuticals recalls all Accusure Insulin Syringes that have been distributed nationwide between 2002 and 2009.[ Price : $8.95]
Members of FDAs Anti-infective Drugs Advisory Committee say it is likely that Human Genome Sciences ABthrax may help treat people ...[ Price : $8.95]
FDA clears a Diagnostic Hybrids 510(k) clearance for the D(3) FastPoint L-DFA Influenza A/ Influenza B Virus Identification Kit.[ Price : $8.95]
Attorney Arnold Friede urges FDA to address legal liability questions arising out of Sidewikis appearing on drug company home page...[ Price : $8.95]
Federal Register Notice: FDA releases a draft revised guidance, SPL Standard for Content of Labeling Technical Qs & As.